Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01704742

Prospective Study of Lymphoproliferative Diseases

A Prospective Clinicopathological Cohort Study of Lymphoproliferative Diseases at Kenyatta National Hospital in Nairobi, Kenya

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
West Virginia University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study will help researchers learn more about non-Hodgkin's lymphoma and Hodgkin's lymphoma and how it is treated in Kenya. Researchers want to see if having certain viruses like Epstein Barr Virus (EBV), Human Immunodeficiency Virus (HIV), and Kaposi's Sarcoma Herpes Virus (KSHV) affects lymphoma. Patients in Kenya who agree to be in this study will let the resesarchers look at their medical record, follow their normal cancer care, and have blood drawn to look at different proteins and viruses. Researchers would also like to look at part of the original tumor that was taken out of each patient. Some of these samples will be stored at Kenyatta National Hospital and research will be done on them later. This study does not involve any change in treatment, but only allows the study team to follow how a patient in Kenya with lymphoma is treated.

Detailed description

Comprehensive prospective cohort study of lymphoproliferative diseases in Nairobi, Kenya.

Conditions

Timeline

First posted
2012-10-11
Last updated
2016-11-08

Locations

2 sites across 2 countries: United States, Kenya

Source: ClinicalTrials.gov record NCT01704742. Inclusion in this directory is not an endorsement.